相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Arginine Vasopressin in Heart Failure
San-e Ishikawa
CIRCULATION JOURNAL (2014)
Low Cardiac Output Stimulates Vasopressin Release in Patients With Stage D Heart Failure - Its Relevance to Poor Prognosis and Reversal by Surgical Treatment
Teruhiko Imamura et al.
CIRCULATION JOURNAL (2014)
Dynamic regulation and dysregulation of the water channel aquaporin-2: a common cause of and promising therapeutic target for water balance disorders
Yumi Noda
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2014)
Hyponatremia as a Predictor for Worsening Heart Failure in Patients Receiving Cardiac Resynchronization Therapy
Kenshiro Arao et al.
CIRCULATION JOURNAL (2013)
Oral Tolvaptan Is Safe and Effective in Chronic Hyponatremia
Tomas Berl et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Reciprocal interaction with G-actin and tropomyosin is essential for aquaporin-2 trafficking
Yumi Noda et al.
JOURNAL OF CELL BIOLOGY (2008)
Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE trial
Mihai Gheorghiade et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry
Mihai Gheorghiade et al.
EUROPEAN HEART JOURNAL (2007)
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure - The EVEREST clinical status trials
Mihai Gheorghiade et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Effects of oral tolvaptan in patients hospitalized for worsening heart failure - The EVEREST outcome trial
Marvin A. Konstam et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia
Robert W. Schrier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Possible vascular role of increased plasma arginine vasopressin in congestive heart failure
T Nakamura et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2006)
Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure -: Results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study
L Klein et al.
CIRCULATION (2005)
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure - A randomized controlled trial
M Gheorghiade et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Urinary excretion of aquaporin-2 water channel exaggerated dependent upon vasopressin in congestive heart failure
H Funayama et al.
KIDNEY INTERNATIONAL (2004)
Pathophysiological roles of arginine vasopressin and aquaporin-2 in impaired water excretion
S Ishikawa et al.
CLINICAL ENDOCRINOLOGY (2003)
分享论文
